Hercules Capital HTGC has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 3 | 2 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 1 | 0 | 0 |
2M Ago | 0 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 1 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $17.8, a high estimate of $18.50, and a low estimate of $17.00. This current average represents a 0.17% decrease from the previous average price target of $17.83.
Deciphering Analyst Ratings: An In-Depth Analysis
In examining recent analyst actions, we gain insights into how financial experts perceive Hercules Capital. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Timothy O'Shea | Wells Fargo | Raises | Overweight | $18.00 | $17.00 |
Casey Alexander | Compass Point | Announces | Neutral | $17.50 | - |
Crispin Love | Piper Sandler | Raises | Overweight | $18.50 | $18.00 |
Vilas Abraham | UBS | Announces | Neutral | $17.00 | - |
Crispin Love | Piper Sandler | Lowers | Overweight | $18.00 | $18.50 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Hercules Capital. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hercules Capital compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Hercules Capital's stock. This analysis reveals shifts in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Hercules Capital's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Hercules Capital analyst ratings.
Unveiling the Story Behind Hercules Capital
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
Unraveling the Financial Story of Hercules Capital
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Negative Revenue Trend: Examining Hercules Capital's financials over 3 months reveals challenges. As of 30 September, 2023, the company experienced a decline of approximately -29.4% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Hercules Capital's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 54.32% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Hercules Capital's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.73%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Hercules Capital's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.85%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Hercules Capital's debt-to-equity ratio stands notably higher than the industry average, reaching 0.99. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: Simplified
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.